Novartis to dock new panel firms’ fees if they miss diversity commitments
Allen & Overy, Simpson Thacher & Bartlett and White & Case are among the firms that have lost their spots on the panel of Swiss pharmaceutical powerhouse Novartis, which has formally concluded its review. Other firms were dropped from the chunky line-up, which includes no fewer than 22 firms. Others that will no longer be […]